**Core Concept**
The dosing of medications in morbidly obese patients can be complex, requiring consideration of **total body weight (TBW)** versus **lean body mass (LBM)**. This principle is crucial in **pharmacokinetics**, as it affects the **volume of distribution** and **clearance** of drugs.

**Why the Correct Answer is Right**
Although the correct answer option is missing, typically, medications that should be dosed according to **TBW** include those that distribute into body water, such as **hydrophilic antibiotics**. The reasoning involves understanding the **pharmacokinetic properties** of the drug, including its **volume of distribution** and how it relates to **body composition**.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific medication, it's challenging to provide a detailed explanation, but generally, medications that are highly lipophilic might be dosed based on **LBM**.
**Option B:** Similarly, without specifics, a common incorrect choice might involve a drug that is known to require **LBM** for dosing calculations.
**Option C:** This option could potentially be incorrect if it represents a medication that does not require **TBW** for dosing.
**Option D:** Assuming this is not the correct answer, it might represent a drug where **LBM** is more appropriate for dosing calculations.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **aminoglycoside antibiotics**, which are **hydrophilic**, are often dosed based on **TBW** in morbidly obese patients to ensure therapeutic levels are achieved without undue risk of toxicity.

**Correct Answer:** Correct Answer: D. Tobramycin